Literature DB >> 15577577

Viral respiratory infections in children with technology dependence and neuromuscular disorders.

Howard B Panitch1.   

Abstract

BACKGROUND: Viral acute respiratory infections represent a significant cause of morbidity and mortality across all ages, especially in patients with chronic underlying conditions. Although recognized anecdotally, the risks of viral infection to those children with chronic underlying conditions rendering them technology dependent, or to those children with neuromuscular disorders, have not been well studied.
METHODS: Studies of children with underlying conditions that result in technology dependence and those with neuromuscular disorders who required hospitalization for respiratory syncytial virus infection are reviewed. Additionally surveys of physician perceptions toward risk factors for severe viral illness and prevention in this population of patients are reported. Possible mechanisms to explain the increased risk of disease severity with viral respiratory infections are explored as well.
RESULTS: Current or recent use of supplemental oxygen is associated with more severe disease in children with chronic underlying conditions, especially bronchopulmonary dysplasia. Supplemental oxygen use may be a marker for several factors known to increase the severity of viral respiratory illnesses. Children with neuromuscular weakness are also likely to experience more severe disease, most likely resulting from compromised airway clearance.
CONCLUSIONS: Although the number of children who are technology-dependent or have severe neuromuscular weakness is small, their risk of severe disease after viral respiratory infection may be similar to that of premature infants or other high risk groups. A better understanding of the factors responsible for severe viral disease in these children would help create better strategies for treatment and prevention.

Entities:  

Mesh:

Year:  2004        PMID: 15577577     DOI: 10.1097/01.inf.0000144670.78558.c7

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  8 in total

1.  Respiratory syncytial virus: diagnosis, treatment and prevention.

Authors:  Lea S Eiland
Journal:  J Pediatr Pharmacol Ther       Date:  2009-04

2.  Respiratory syncytial virus infection in 406 hospitalized premature infants: results from a prospective German multicentre database.

Authors:  Arne Simon; Roland A Ammann; Anja Wilkesmann; Anna M Eis-Hübinger; Oliver Schildgen; Edda Weimann; Hans U Peltner; Peter Seiffert; Angela Süss-Grafeo; Jessie R Groothuis; Johannes Liese; Ralf Pallacks; Andreas Müller
Journal:  Eur J Pediatr       Date:  2007-02-16       Impact factor: 3.183

3.  Respiratory syncytial virus infection in children with neuromuscular impairment.

Authors:  Arne Simon; Julia Prusseit; Andreas Müller
Journal:  Open Microbiol J       Date:  2011-12-30

Review 4.  Prevention of serious respiratory syncytial virus-related illness. I: Disease pathogenesis and early attempts at prevention.

Authors:  Jessie R Groothuis; J Michael Hoopes; Val G Hemming Jessie
Journal:  Adv Ther       Date:  2011-02-04       Impact factor: 3.845

Review 5.  Antimicrobial therapy in childhood asthma and wheezing.

Authors:  Arne Simon; Oliver Schildgen
Journal:  Treat Respir Med       Date:  2006

6.  Lower Respiratory Tract Infections in Pediatric Patients with Severe Neurological Impairments: Clinical Observations and Perspectives in a Palliative Care Unit.

Authors:  Maximilian David Mauritz; Carola Hasan; Pia Schmidt; Arne Simon; Markus Knuf; Boris Zernikow
Journal:  Children (Basel)       Date:  2022-06-08

7.  SARS-CoV-2 infection in technology-dependent children: a multicenter case series.

Authors:  Joan Robinson; Tammie Dewan; Shaun K Morris; Ari Bitnun; Peter Gill; Tala El Tal; Ronald M Laxer; E Ann Yeh; Carmen Yea; Rolando Ulloa-Gutierrez; Helena Brenes-Chacon; Adriana Yock-Corrales; Gabriela Ivankovich-Escoto; Alejandra Soriano-Fallas; Marcela Hernandez-de Mezerville; Jesse Papenburg; Marie-Astrid Lefebvre; Alireza Nateghian; Behzad Haghighi Aski; Ali Manafi; Rachel Dwilow; Jared Bullard; Suzette Cooke; Lea Restivo; Alison Lopez; Manish Sadarangani; Ashley Roberts; Nicole Le Saux; Jennifer Bowes; Rupeena Purewal; Janell Lautermilch; Jacqueline K Wong; Dominique Piche; Karina A Top; Cheryl Foo; Luc Panetta; Joanna Merckx; Michelle Barton
Journal:  Infection       Date:  2022-08-29       Impact factor: 7.455

8.  Mortality in children hospitalised with respiratory syncytial virus infection in Singapore.

Authors:  Ming Wei Lee; Anne En Goh
Journal:  Singapore Med J       Date:  2020-05-27       Impact factor: 1.858

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.